Skip to main content

Want a detailed portfolio tracker?

NSPR
NASDAQ
$0.70

InspireMD Inc (NSPR)

InspireMD, Inc., a medical device company, is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular disease in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
Website: https://www.inspiremd.com
68 analysts
Strong Buy
Target: $3.67 (+420.95%)

Market Cap

$34M

P/B Ratio

0.77

Revenue 5Y CAGR

+34.58%

FCF 5Y CAGR

+30.81%

Price Chart

Valuation
Market Cap$34M
Forward P/E11.70
P/S3.11
P/B0.77
Profitability
Total Revenue (TTM)$11M
Gross Profit (TTM)$3.04M
EBITDA$424M
Operating Margin-411.4%
EPS-$1.27
Growth & Risk
EPS 5Y CAGR-7.93%
Revenue 5Y CAGR+34.58%
FCF 5Y CAGR+30.81%
Sharpe Ratio-1.83